¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£©
¼¶±ð: ²©Ê¿
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-20   

µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£©

µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© -#x\E%v.F  
G)7sXEe  
  Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© pj]<i.p  
  1¡¢Co-stimulators (or co-stimulating molecules) OhEL9"\<  
  2¡¢NK-kB 1PSb72h<  
  3¡¢Immunoglobulin superfamily pASVnXJZ  
  4¡¢antigen-presenting cell (APC) _y UFe&  
  5¡¢death domain xK3;/!\`  
  6¡¢CCR and CXCR R 0}%   
  7¡¢Lectin (or mitogen) I&Y(]S,cU  
  8¡¢Clusters of differentiation, CD) nT"z(\i.!J  
  9¡¢B7 family e_V(G  
  10¡¢Cytotoxic T lymphocyte, CTL) [dMxr9M  
  11¡¢IL-15 and IL-15 receptor (IL-15R) hgGcUpJy?  
  12¡¢MHC restriction 4>*`26  
  13¡¢Affinity-chromatography $ 1U%E  
  14¡¢Cyctosprin A, CsA za7wNe(s  
  15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) e$=|-J z  
y e'5 A   
  ¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 3yN1cd"#?  
  1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 sa*-B  
  2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ o1\8>Ew  
  3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ ~vmY 2h\  
Ek3O{<  
  Èý¡¢ÎÊ´ðÌ⣨25·Ö£© 1zRO== b  
  1¡¢Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ X6RM2  
  ѪҺ²¡Ñ§×¨Òµ£º jLTs1`I/F  
  2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
Ãâ·Ñ¿¼²©ÍøÍøÖ·ÊÇʲô? ÕýÈ·´ð°¸:freekaobo.com
°´"Ctrl+Enter"Ö±½ÓÌá½»